Internal Medicine, Nephrology · West Springfield, MA
NPI
1356331474
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
134 Capital Dr Ste E
West Springfield, MA, 01089
Phone (413) 733-0010
Groups this clinician bills Medicare through
Medicare paid, 2024
$194K
6,083 services
Medicare patients, 2024
616
Average age 72
Drug cost, 2024
$827K
3,987 prescriptions
Company payments, 2025
$101
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony E Poindexter was code Q5106 (injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units), 1,544 times for 20 patients. In total Anthony E Poindexter billed 6,083 services in 28 codes, and Medicare paid $194K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 1,544 | 20 | $5.79 | $8,947 |
| 99214 Office E&M - Established | Office | 1,099 | 413 | $73.69 | $81K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 939 | 378 | $12.79 | $12K |
| 96372 Injection Administration | Office | 157 | 20 | $10.78 | $1,692 |
| 99232 Hospital E&M - Subsequent | Facility | 152 | 85 | $61.54 | $9,354 |
| 90961 ESRD Related Services (not dialysis) | Office | 137 | 33 | $245.53 | $34K |
| 85018 Blood Count | Office | 125 | 20 | $2.32 | $290 |
| 90960 ESRD Related Services (not dialysis) | Office | 69 | 16 | $289.48 | $20K |
| 90962 ESRD Related Services (not dialysis) | Office | 40 | 26 | $166.39 | $6,656 |
| 99231 Hospital E&M - Subsequent | Facility | 33 | 24 | $37.51 | $1,238 |
| 99204 Office E&M - New | Office | 28 | 28 | $108.09 | $3,027 |
| 99222 Hospital E&M - Initial | Facility | 23 | 22 | $97.95 | $2,253 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 22 | 19 | $34.04 | $749 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 12 | $93.25 | $1,958 |
| 99223 Hospital E&M - Initial | Facility | 21 | 21 | $135.87 | $2,853 |
By year: 2022 $273K for 11,010 services; 2023 $205K for 5,697 services; 2024 $194K for 6,083 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85018 Blood Count | 125 | 20 | $2.32 | $290 |
Medicare prescription drug claims, 2024
In 2024, the drug Anthony E Poindexter prescribed most often to Medicare patients was Amlodipine Besylate, with 225 prescriptions and refills. In total Anthony E Poindexter wrote 3,987 Medicare prescriptions that cost $827K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 225 | 484 | 69 | $1,537 |
| Carvedilol Generic | 222 | 486 | 67 | $3,057 |
| Nifedipine Er Nifedipine | 170 | 348 | 46 | $4,849 |
| Losartan Potassium Generic | 159 | 370 | 38 | $1,795 |
| Prednisone Generic | 155 | 231 | 34 | $1,581 |
| Lisinopril Generic | 142 | 334 | 37 | $1,207 |
| Torsemide Generic | 119 | 213 | 31 | $1,805 |
| Pantoprazole Sodium Generic | 86 | 131 | 24 | $1,308 |
| Mycophenolic Acid Mycophenolate Sodium | 84 | 112 | 18 | $4,231 |
| Atorvastatin Calcium Generic | 79 | 162 | 23 | $986 |
| Oxycodone Hcl Generic | 75 | 75 | Under 11 | $2,508 |
| Tacrolimus Generic | 71 | 109 | 14 | $4,492 |
| Valganciclovir Hcl Generic | 70 | 95 | 25 | $9,080 |
| Envarsus Xr Tacrolimus | 70 | 104 | 17 | $66K |
| Allopurinol Generic | 66 | 166 | 23 | $602 |
Brand drugs: 533 claims; generic drugs: 3,408 claims; opioid claims: 110.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony E Poindexter $101 ($101 in general payments such as food, travel and fees) from 2 companies. The largest payer was Veloxis Pharmaceuticals, Inc. with $96.71.
| Company | Payments | Amount |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 1 | $96.71 |
| Travere Therapeutics, Inc. TVTX | 4 | $4.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.